A detailed history of National Pension Service transactions in Abb Vie Inc. stock. As of the latest transaction made, National Pension Service holds 3,351,522 shares of ABBV stock, worth $588 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
3,351,522
Previous 2,910,745 15.14%
Holding current value
$588 Million
Previous $499 Million 32.57%
% of portfolio
0.65%
Previous 0.57%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $72.2 Million - $87.9 Million
440,777 Added 15.14%
3,351,522 $662 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $9.34 Million - $10.9 Million
60,331 Added 2.12%
2,910,745 $499 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $6.12 Million - $6.98 Million
38,307 Added 1.36%
2,850,414 $519 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $7.46 Million - $8.4 Million
54,185 Added 1.96%
2,812,107 $436 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $6.45 Million - $7.47 Million
48,301 Added 1.78%
2,757,922 $411 Million
Q2 2023

Aug 15, 2023

BUY
$132.51 - $164.9 $17.8 Million - $22.1 Million
134,152 Added 5.21%
2,709,621 $365 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $661,012 - $761,254
4,571 Added 0.18%
2,575,469 $410 Million
Q4 2022

Feb 23, 2023

BUY
$138.31 - $165.87 $6.47 Million - $7.76 Million
46,808 Added 1.85%
2,570,898 $416 Million
Q4 2022

Feb 17, 2023

BUY
$138.31 - $165.87 $6.47 Million - $7.76 Million
46,808 Added 1.85%
2,570,898 $415 Million
Q3 2022

Feb 23, 2023

SELL
$134.21 - $153.93 $6.28 Million - $7.21 Million
-46,808 Reduced 1.82%
2,524,090 $339 Million
Q3 2022

Nov 17, 2022

BUY
$134.21 - $153.93 $8.39 Million - $9.63 Million
62,548 Added 2.54%
2,524,090 $360 Million
Q2 2022

Aug 17, 2022

BUY
$137.62 - $174.96 $24.5 Million - $31.2 Million
178,284 Added 7.81%
2,461,542 $377 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $8.13 Million - $10.1 Million
61,619 Added 2.77%
2,283,258 $370 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $2.96 Million - $3.75 Million
-27,581 Reduced 1.23%
2,221,639 $301 Million
Q3 2021

Nov 18, 2021

SELL
$106.4 - $120.78 $654,998 - $743,521
-6,156 Reduced 0.27%
2,249,220 $243 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $3.64 Million - $4.05 Million
34,551 Added 1.56%
2,255,376 $254 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $5.43 Million - $5.97 Million
53,052 Added 2.45%
2,220,825 $240 Million
Q4 2020

Feb 19, 2021

BUY
$80.49 - $108.67 $4.67 Million - $6.3 Million
57,966 Added 2.75%
2,167,773 $232 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $28.1 Million - $37.6 Million
382,923 Added 22.17%
2,109,807 $207 Million
Q1 2020

May 27, 2020

BUY
$64.5 - $97.79 $1.11 Million - $1.69 Million
17,231 Added 1.01%
1,726,884 $132 Million
Q4 2019

Feb 21, 2020

BUY
$72.13 - $90.25 $6.23 Million - $7.79 Million
86,315 Added 5.32%
1,709,653 $151 Million
Q3 2019

Nov 15, 2019

BUY
$62.98 - $75.72 $4.77 Million - $5.74 Million
75,740 Added 4.89%
1,623,338 $123 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $4.59 Million - $5.86 Million
69,793 Added 4.72%
1,547,598 $113 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $4.11 Million - $4.84 Million
53,267 Added 3.74%
1,477,805 $119 Million
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $6.64 Million - $8.19 Million
85,336 Added 6.37%
1,424,538 $115 Million
Q3 2018

Nov 15, 2018

BUY
$88.91 - $98.84 $1.25 Million - $1.39 Million
14,058 Added 1.06%
1,339,202 $127 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $4.07 Million - $4.81 Million
45,306 Added 3.54%
1,325,144 $122 Million
Q1 2018

Apr 13, 2018

BUY
$92.01 - $123.21 $163,041 - $218,328
1,772 Added 0.14%
1,279,838 $121 Million
Q4 2017

Jan 17, 2018

BUY
$89.56 - $98.21 $731,973 - $802,670
8,173 Added 0.64%
1,278,066 $124 Million
Q3 2017

Oct 16, 2017

BUY
$69.85 - $89.22 $88.7 Million - $113 Million
1,269,893
1,269,893 $113 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.